Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
6.00
+0.06 (1.01%)
Last updated: Feb 11, 2026, 2:42 PM HKT
HKG:6922 Revenue
Cryofocus Medtech (Shanghai) had revenue of 51.11M CNY in the half year ending June 30, 2025, with 170.20% growth. This brings the company's revenue in the last twelve months to 85.16M, up 105.16% year-over-year. In the year 2024, Cryofocus Medtech (Shanghai) had annual revenue of 53.53M with 30.72% growth.
Revenue (ttm)
85.16M CNY
Revenue Growth
+105.16%
P/S Ratio
15.58
Revenue / Employee
473.12K CNY
Employees
180
Market Cap
1.45B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53.53M | 12.58M | 30.72% |
| Dec 31, 2023 | 40.95M | 13.80M | 50.83% |
| Dec 31, 2022 | 27.15M | 4.72M | 21.06% |
| Dec 31, 2021 | 22.43M | 13.37M | 147.69% |
| Dec 31, 2020 | 9.05M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.71B |
| Gaush Meditech | 1.58B |
| Vincent Medical Holdings | 869.70M |
| Peijia Medical | 731.61M |
| Acotec Scientific Holdings | 649.64M |
| MicroTech Medical (Hangzhou) | 482.95M |
| Venus Medtech (Hangzhou) | 468.17M |
| Shanghai HeartCare Medical Technology Corporation | 367.02M |